Pharsight

Drugs that contain Dronabinol

1. Syndros patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US10265293 BENUVIA OPERATIONS Oral cannabinoid formulations
Aug, 2028

(4 years from now)

US9345771 BENUVIA OPERATIONS Oral cannabinoid formulations
Aug, 2028

(4 years from now)

US11253472 BENUVIA OPERATIONS Oral cannabinoid formulations
Aug, 2028

(4 years from now)

US8222292 BENUVIA OPERATIONS Liquid cannabinoid formulations
Aug, 2028

(4 years from now)

Market Authorisation Date: 23 March, 2017

Treatment: NA

Dosage: SOLUTION;ORAL

How can I launch a generic of SYNDROS before it's drug patent expiration?
More Information on Dosage

SYNDROS family patents

Family Patents